Abstract Details

Title Reactivation during switch from natalizumab to fingolimod: is it predictible?

Topic Multiple Sclerosis

Presentation(s) (-)

Poster/Presentation
Number 212

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Adil Maarouf PRESENTER	Adil Maarouf has nothing to disclose.
	No disclosure on file
Adrien Maitrot	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
Marie-Pierre Chaunu	No disclosure on file
	No disclosure on file
Ayman P. Tourbah (Department of Neurology University Hospital Raymond Poincaré)	No disclosure on file

��ɫ����